Trimethobenzamide Hydrochloride

CHEMBL1200887 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
424.9 g/mol
LogP
Phase
4

Trimethobenzamide hydrochloride is the hydrochloride salt of trimethobenzamide, an antiemetic that inhibits dopamine receptors in the medullary chemoreceptor trigger zone to control nausea and vomiting. It is available in oral and injectable formulations, commonly used for nausea relief in Parkinson's disease patients and postoperative settings. The hydrochloride salt enhances aqueous solubility for parenteral administration.

Berat Molekul

424,9000 g/mol

TPSA

69,30 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.Cl

InChI

InChI=1S/C21H28N2O5.ClH/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4;/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24);1H

Molecular Formula

C21H29ClN2O5

HBD / HBA

2 / 6

Ikatan yang Dapat Dirotasi

10

Atom Berat

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Trimethobenzamide hydrochloride is the hydrochloride salt of trimethobenzamide, an antiemetic that inhibits dopamine receptors in the medullary chemoreceptor trigger zone to control nausea and vomiting. It is available in oral and injectable formulations, commonly used for nausea relief in Parkinson's disease patients and postoperative settings. The hydrochloride salt enhances aqueous solubility for parenteral administration.

Yes, Trimethobenzamide Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200887. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 68385. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.